Where is India’s pharma market headed? Regulatory infrastructure must be put in place to ensure global quality
5 years, 8 months ago

Where is India’s pharma market headed? Regulatory infrastructure must be put in place to ensure global quality

Firstpost  

The pace at which the “pharmacy of the world” is growing, there’s no denying that India is utilising its full potential. The other side—Indian drugs are failing at the World Health Organisation quality standards and those required by the western drug regulating authorities like the Food and Drug Administration. In fact, the ‘Special 301 Report’ by the United States Trade Representatives slammed India and China as leading sources of counterfeit medicines distributed globally with 20 percent of all pharmaceutical products sold in the Indian market is estimated to be counterfeit. If you look at the quality of drugs manufactured for the domestic market, many manufacturing units are reportedly not compliant with the WHO’s good manufacturing practices or good laboratory practices. There are many other issues of quality, partiality in procurement modalities and irrational combinations that affect the timely availability/supply of right drugs By opening Jan Aushadhi centres without supply and quality assurances, and without substantially increasing the health budget, any mass movement to achieve universal health coverage is bound to fail.

Health India Market Drugs Quality Indian Pharmaceutical Pharma Drug  regulatory  drugs  quality  health  market  pharma  headed  domestic  standards  generics  ensure  drug  place  india  infrastructure  global  indias  pharmaceutical

History of this topic

India’s $300 billion blueprint for global biopharma leadership
1 week ago

India’s $300 billion blueprint for global biopharma leadership

Hindustan Times  

India is on the threshold of a transformative leap in the biopharmaceutical sector. To lead this evolution, India must strengthen research and development investments, build an integrated biomanufacturing ecosystem, and build supply chain resilience, ensuring a competitive edge in the global biopharma landscape. India must accelerate indigenisation of key bioprocessing inputs such as single use consumables, critical raw materials, buffers, …

Govt floats EOI for doing major Research & Development in pharma medtech sector and drugs
Trending News
3 weeks ago

Govt floats EOI for doing major Research & Development in pharma medtech sector and drugs

Live Mint  

New Delhi: The government has sought expressions of interest for research & development projects to develop novel technologies in medicine, including medical devices and drugs for communicable and non-communicable diseases. Under this component, the government will finance companies focused on doing R&D in priority areas, including drug discovery & development, medical devices, stem cell therapy, and treatment of drug-resistant patients. …

India eyes global pharma dominance with a ₹5,000 crore revitalisation plan
Trending News
1 month ago

India eyes global pharma dominance with a ₹5,000 crore revitalisation plan

Live Mint  

India is making a push to move beyond its dominance in generic drugs and establish itself as a hub for pharmaceutical innovation. The government will invite expressions of interest in March for a ₹5,000 crore funding corpus aimed at accelerating research in drug discovery, medical technology, and stem cell therapy, with bid submissions expected in April. The initiative, part of …

High tariff to force India’s pharma sector to look beyond the U.S.
1 month ago

High tariff to force India’s pharma sector to look beyond the U.S.

The Hindu  

Its time for Indian pharma companies to look beyond the U.S. market as the Trump administration has threatened to impose 25% tariff on pharmaceutical imports. This move would disrupt India’s dominant position in the U.S. market, where it supplies over 45% of its generic medicines, industry officials said. Being the ‘Lifeline to global healthcare,’ our pharma segment must also invest …

‘Pharmacy of the world’ pins hope on Modi govt to avert Trump tariff crisis
1 month, 1 week ago

‘Pharmacy of the world’ pins hope on Modi govt to avert Trump tariff crisis

Firstpost  

Government data shows that the US is the biggest market for Indian drugmakers. The country, which boasts of being the ‘pharmacy of the world’ produces cheaper generic versions of complex innovative drugs which are traded off to over 200 countries Representational image. Pexels India’s pharmaceutical industry hopes that bilateral talks between New Delhi and Washington could help avert the crisis …

‘Pharmacy of the world’ pins hope on Modi govt to avert Trump tariff crisis
1 month, 1 week ago

‘Pharmacy of the world’ pins hope on Modi govt to avert Trump tariff crisis

Firstpost  

Government data shows that the US is the biggest market for Indian drugmakers. The country, which boasts of being the ‘pharmacy of the world’ produces cheaper generic versions of complex innovative drugs which are traded off to over 200 countries India’s pharmaceutical industry hopes that bilateral talks between New Delhi and Washington could help avert the crisis triggered by US …

Strategic budget interventions can position Indian pharma for global leadership
2 months, 1 week ago

Strategic budget interventions can position Indian pharma for global leadership

Live Mint  

Finance minister Nirmala Sitharaman is all set to present the budget for FY26 on 1 February. The upcoming Union budget presents a unique opportunity to accelerate the growth of India’s pharmaceutical and life sciences sector. By allocating substantial funds for healthcare, enhancing the accessibility and affordability of life-saving medicines, prioritizing cutting-edge research, and advancing infrastructure, the government can drive growth, …

Expiry of Rs 12k cr patented US drugs a big opportunity for pharma
2 months, 4 weeks ago

Expiry of Rs 12k cr patented US drugs a big opportunity for pharma

Deccan Chronicle  

Chennai: The US will see expiry of drugs worth Rs 12000 crore between 2025 and 2028 and this will be a huge opportunity for Indian generic drug manufacturers. The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name Keytruda by Merck and Co., Eliquis sold by Bristol Myers Squibb …

Indian pharma sector to grow 9-11% in FY26: From Lupin to Max Healthcare—Top 5 stock picks by Motilal Oswal for 2025
3 months ago

Indian pharma sector to grow 9-11% in FY26: From Lupin to Max Healthcare—Top 5 stock picks by Motilal Oswal for 2025

Live Mint  

The Indian pharmaceutical industry will likely grow 9-11 per cent in 2025-26, led by price hikes, new domestic launches, and increased export demand from regulated markets. The top five pharma stock picks for 2025 by Motilal Oswal Wealth Management are as follows: Top 5 pharma stocks to buy in 2025 • Mankind Pharma: According to Motilal Oswal, Mankind Pharma continues …

Local to global: 14 nations keen to adopt India’s generic pharmacy model
4 months, 2 weeks ago

Local to global: 14 nations keen to adopt India’s generic pharmacy model

Live Mint  

New Delhi: Inspired by India's efforts to make affordable medicines accessible to the public, 14 countries from the Global South, including Taliban-ruled Afghanistan, are considering adopting India's generic pharmacy model, according to two people familiar with the development. While 11 countries, including Nepal, Sri Lanka, Bhutan, Ghana, Suriname, Nicaragua, Mozambique, and the Solomon Islands, have recognized Indian standards for drugs …

India's pharma, meditech exports expected to sustain momentum despite global slowdown: Senior official
5 months, 3 weeks ago

India's pharma, meditech exports expected to sustain momentum despite global slowdown: Senior official

New Indian Express  

NEW DELHI: Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal despite a slowdown in the global economy, a senior government official said on Wednesday. Even though there is a general slowdown in exports globally, the good news is that the Indian pharmaceuticals, biotech, and bulk drug exports have grown double-digit …

Health Talk | Why India waiving off local clinical trials for globally approved new drugs is good news
7 months, 2 weeks ago

Health Talk | Why India waiving off local clinical trials for globally approved new drugs is good news

Hindustan Times  

On August 7, India’s drugs regulatory agency, Central Drugs Standard Control Organisation, issued an order that allowed waiving off local clinical trials for approval of certain categories of new and novel drugs in the Indian market that have already been approved for use globally by regulators of countries that follow strict quality control. Local clinical trials or bridging studies as …

India To Update Rules To Match Global Standards For Medicines After Flak Over Drugs
8 months ago

India To Update Rules To Match Global Standards For Medicines After Flak Over Drugs

News 18  

The long-pending move to make impurity standards for Indian medicines stricter is coming soon, News18 learnt. The Indian Pharmacopoeia Commission is updating its rules to match global standards to check harmful elements in medicines – a significant shift from the current lenient checks on medicines, especially those sold locally. HOW INDIA PLANS TO IMPROVE STANDARDS The Indian Pharmacopoeia Commission, as …

DCGI inspection brings curtains down on 36% of 400 pharma units; plans for new digital projects
9 months ago

DCGI inspection brings curtains down on 36% of 400 pharma units; plans for new digital projects

Live Mint  

Mumbai: The Drug Controller General of India Rajeev Raghuvanshi on Thursday revealed that the Central Drugs Standard Control Organization has conducted risk-based inspections of over 400 pharmaceutical manufacturing units over the past year and a half, resulting in the closure of 36% of these facilities. “We have been successfully doing risk-based inspections and inspected about 400 manufacturing units and I …

How is India streamlining the pharma sector? | Explained
10 months, 2 weeks ago

How is India streamlining the pharma sector? | Explained

The Hindu  

The story so far: India’s drug regulator, the Central Drugs Standard Control Organisation, has withdrawn powers delegated to State licensing authorities to issue NOCs for manufacture of unapproved, banned or new drugs for export purposes. This latest announcement covering drugs for export comes at a time when India has been under scrutiny for allegations of supplying substandard drugs causing health …

Navigating Legal Challenges In The Development Of The Pharmaceutical Sector In India
1 year, 2 months ago

Navigating Legal Challenges In The Development Of The Pharmaceutical Sector In India

ABP News  

New Delhi, January 25: India's pharmaceutical sector, a key contributor to the nation's economy, has encountered significant legal challenges influencing its growth trajectory. Balancing data exclusivity, protecting clinical trial data, and ensuring timely access to generic drugs is a delicate task crucial for fostering innovation and affordability in medicine. The pharmaceutical sector in India faces challenges beyond patents, including combating …

Nigeria Tightens Regulations on Indian Pharma Exports, New Standards May Spark Industry Concerns
1 year, 2 months ago

Nigeria Tightens Regulations on Indian Pharma Exports, New Standards May Spark Industry Concerns

News 18  

The Nigerian drug regulator has recently heightened its standards for Indian drug makers exporting to the country, News18 has learnt. According to the National Agency for Food and Drug Administration and Control — the health regulator of Nigeria — the quality of Active Pharmaceutical Ingredients used in finished pharmaceutical products manufacturing directly impacts the “safety, efficacy, quality, regulatory compliance, consistency, …

India pharma industry to reach $130 billion by 2030
1 year, 4 months ago

India pharma industry to reach $130 billion by 2030

The Hindu  

The Indian pharmaceutical industry is expected to reach $130 billion mark by 2030 said a top industry executive at the CPHI & PMEC India expo. This growth is propelled by expanding market opportunities, heightened demand in the USA, and critical shortages of medicines in the U.S. and Europe,” said Dr. Veeramani S.V., Chairman, Pharmaceuticals Export Promotion Council of India. Anil …

Pharma Star: India Steering Global Supply Chain Away from China - News18
1 year, 4 months ago

Pharma Star: India Steering Global Supply Chain Away from China - News18

News 18  

India’s pharmaceutical industry is at a pivotal juncture. With its well-established prowess in generic drug manufacturing, it has been called on by the world to build a reliable base for the manufacture of raw materials, which offers an opportunity for India to attract the bulk of the pharmaceutical supply chains away from China. “India has started producing 45 APIs after …

Opinion: India could write the next chapter of global pharma triumph
1 year, 6 months ago

Opinion: India could write the next chapter of global pharma triumph

India Today  

India’s G20 presidency has significant implications for the pharmaceutical industry, focussing on improving global health emergency preparedness, fostering industry collaborations, and harnessing digital health potential. India’s pharma industry has established its position as a global hub for drug manufacturing, bolstered by a well-established domestic production infrastructure and a pool of highly-skilled, cost-effective workforce. New avenues for growth Not surprisingly, global …

Mega schemes for pharma development, med-tech innovation and reducing dependency API import to be announced next month
1 year, 7 months ago

Mega schemes for pharma development, med-tech innovation and reducing dependency API import to be announced next month

The Hindu  

The Ministry of Chemicals and Fertilizers will soon announce a ₹5,000-crore research programme aimed at reducing India’s import dependency on Active Pharmaceutical Ingredients and promoting discovery of new drug molecules. “The policies aim to engage nine established pharmaceutical companies in impact research across six priority areas with prestigious government institutes. It also approved a new Scheme for Promotion of Research …

Indian pharma industry to hit $57 billion by FY25
1 year, 8 months ago

Indian pharma industry to hit $57 billion by FY25

Live Mint  

New Delhi: Domestic pharmaceutical industry will likely hit $57 billion by FY25, along with expansion in operating margins by 100-150 basis points, according to a report by CareEdge Ratings. During FY18 to FY23, the Indian pharmaceutical industry has logged a a compound annual growth rate of 6-8%, primarily driven by an 8% increase in exports and a 6% rise in …

Explained | Why are Indian drugmakers under the lens?
1 year, 8 months ago

Explained | Why are Indian drugmakers under the lens?

The Hindu  

The story so far: Since October last year, Indian pharma companies have been under constant international scrutiny for exporting allegedly contaminated drugs, which have led to deaths of children. Recently, Nigeria raised the red flag on two oral drugs; Cameroon too sounded an alarm over another cough syrup reportedly made in India when several children died. For instance, Ms. Jhaveri …

India ought to work far harder at being the world’s pharmacy
1 year, 9 months ago

India ought to work far harder at being the world’s pharmacy

Live Mint  

Indians have long been proud of their pharmaceutical sector. More than a decade ago, Ranbaxy Laboratories Ltd— then considered the jewel of India’s pharma sector —had to recall tens of thousands of bottles of its generic version of Lipitor for fear that they contained tiny fragments of glass. The saga left neither India’s pharma sector nor its regulators looking very …

‘Indian pharma industry likely to grow to $130 billion in size by 2030’
1 year, 9 months ago

‘Indian pharma industry likely to grow to $130 billion in size by 2030’

The Hindu  

The Indian pharmaceutical industry is projected to grow at a CAGR of over 10% to reach a size of $130 billion by 2030, industry officials said. Supported by the government’s policies and initiatives like ‘Pharma Vision 2020’ and ‘Make in India’, India aims to become a global pharmaceutical hub.” Stating that the pharmaceutical industry is moving towards transparency and visibility, …

Indian Bulk Drugs Industry Poised For Growth: Jayesh
1 year, 9 months ago

Indian Bulk Drugs Industry Poised For Growth: Jayesh

Deccan Chronicle  

HYDERABAD: The bulk drugs industry is at the cusp of an evolution with start-ups and technology players getting into the value chain. Focus should also be on the environment, social issues, and governance as in the days to come the buyer countries will insist on the processes adopted in the manufacturing and packaging of drugs, said principal secretary Jayesh Ranjan. …

Pharma sector needs to focus on quality and affordability: Mandaviya
1 year, 10 months ago

Pharma sector needs to focus on quality and affordability: Mandaviya

Live Mint  

New Delhi: Minister for health and chemicals & fertilizers Mansukh Mandaviya on Saturday advocated for a renewed emphasis on quality, affordability, and innovation in the pharmaceutical industry. Mandaviya chaired a roundtable meeting with the leading CEOs of pharmaceutical industry at the 8th International Conference on Pharma and Medical Device Sector. To maintain its status as the world’s pharmacy, India must …

There can be no laxity with the quality of medicine: Health Minister
1 year, 10 months ago

There can be no laxity with the quality of medicine: Health Minister

The Hindu  

If India wants to continue being the pharmacy of the world there can be no laxity on the quality of pharmaceutical products, said Health Minister Mansukh Mandaviya speaking at the 8th international conference on the pharma and medical device sector on Friday. The Health Minister also unveiled the National Medical Devices Policy, 2023, and launched the Export Promotion Council for …

India's Pharma Sector In 2023 And Beyond: Shaping New Paradigm With Innovation And Easier Regulatory Processes
1 year, 11 months ago

India's Pharma Sector In 2023 And Beyond: Shaping New Paradigm With Innovation And Easier Regulatory Processes

News 18  

Recently, Union Health Minister, Mansukh Mandaviya highlighted that research and innovation are necessary for the sustained growth of the pharmaceuticals sector. In line with this, the government has initiated various steps such as pharma innovation, new programme to promote research and innovation in pharmaceuticals is being taken up through Centres of Excellences While India’s pharma industry has progressed by leaps …

Safety concerns over e-pharma put Centre in a spot
1 year, 11 months ago

Safety concerns over e-pharma put Centre in a spot

The Hindu  

Central Health Ministry sources say that they are in no mood to give the e-pharma platforms a “free run’’, calling the move far too dangerous. Unlimited accessibility to medicines through e-pharmacy, sale of sub-standard, habit-forming medicines, profiling of patients and buyers, and illegal data collection are the main concerns,’’ said the source, adding that this dynamic industry must be handled …

Drafting a road map to bolster the pharma sector
2 years ago

Drafting a road map to bolster the pharma sector

Hindustan Times  

India is known as the pharmacy of the world, and there are several good reasons why it is called so. The country exports pharma products to over 200 countries, and its domestic pharmaceutical industry includes a strong network of 3,000 drug companies and 10,500 manufacturing units. The meeting, attended by representatives from the Union ministry and state governments, had five …

Indian pharma industry must focus on innovation, say industry leaders
2 years, 1 month ago

Indian pharma industry must focus on innovation, say industry leaders

Deccan Chronicle  

HYDERABAD: The Indian pharma industry — also known as the world’s pharmacy — needs to focus on innovation to stay relevant, industry leaders opined at the CEO Conclave of BioAsia here on Friday. Hari S. Bhartia, co-chairman and managing director of Jubilant Pharmova, said the Indian pharma industry could get a huge market if it could offer highly innovative drugs …

Can a centralized regulation help drug quality?
2 years, 1 month ago

Can a centralized regulation help drug quality?

Live Mint  

Waking up to recent deaths in Gambia, Uzbekistan and the US, allegedly caused by toxic and contaminated drugs made in India, the Centre is reportedly planning to centralize drug regulation. The Central Drugs Standard Control Organization, which has zonal and sub-zonal offices and labs across the country, is the apex regulatory body. The state regulators look after licensing and auditing …

Patralekha Chatterjee | Drug regulators in India must do better oversight
2 years, 1 month ago

Patralekha Chatterjee | Drug regulators in India must do better oversight

Deccan Chronicle  

Is Big Pharma hatching a plot to smear India’s low-cost generic drug makers? The World Health Organisation said laboratory tests showed that Marion Biotech’s cough syrups contained unacceptable levels of diethylene glycol and/or ethylene glycol as contaminants. Problems afflicting India’s drug regulatory system is an old story, says Amar Jesani, a well-known public health researcher and editor of Indian Journal …

New programme to promote research in pharma: FM Nirmala Sitharaman
2 years, 1 month ago

New programme to promote research in pharma: FM Nirmala Sitharaman

Hindustan Times  

Finance Minister Nirmala Sitharaman on Wednesday announced launch of a new programme to promote research in pharmaceuticals with a view to promoting growth of the sector. Union Finance Minister Nirmala Sitharaman carrying the tablet leaves from the Ministry of Finance to present and read out the Union Budget 2023 at the Parliament, at North Block, in New Delhi on Wednesday. …

Domestic pharmaceutical market to reach $130 billion by 2030: Economic Survey
2 years, 2 months ago

Domestic pharmaceutical market to reach $130 billion by 2030: Economic Survey

The Hindu  

India's domestic pharmaceutical market is estimated to reach $130 billion by 2030 and the pharma industry has sustained its growth momentum after the pandemic, according to the Economic Survey 2022-23. On the home front, the Survey said, "India's domestic pharmaceutical market is estimated at $41 billion in 2021 and is likely to grow to 65 billion by 2024 and is …

Budget 2023: An Opportunity To Push India's Pharma Industry Development
2 years, 2 months ago

Budget 2023: An Opportunity To Push India's Pharma Industry Development

News 18  

The Union Budget 2023-24 will be presented on February 1 against the backdrop of a global recessionary fear. Several public sector schemes launched in the past few years, including the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission, have focused on building last-mile infrastructure. Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance Secretary General Sudarshan …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
2 years, 2 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

How are drug prices regulated in India? | In Focus podcast
2 years, 2 months ago

How are drug prices regulated in India? | In Focus podcast

The Hindu  

In mid-December, a government department told the Kerala High Court that Ribociclib, a drug prescribed for a type of breast cancer, did not meet the conditions necessary to issue a compulsory licence. Drug prices have evoked national interest following the COVID-19 pandemic, which saw widespread reporting of desperate patients turning to the black market for drugs and devices. How are …

'Bid to sully India’s tag as pharmacy of the world'
2 years, 3 months ago

'Bid to sully India’s tag as pharmacy of the world'

Live Mint  

There is an attempt to tarnish India’s reputation as the pharmacy of the world, and it is the government’s duty to safeguard India’s image, Union minister of health and family welfare, and chemical and fertilizer Dr Mansukh Mandaviya said, referring to the controversy around the death of 66 children in Gambia, allegedly after consuming Maiden Pharma’s cough syrup. During the …

India@75: Phenomenal journey of the pharma industry
2 years, 4 months ago

India@75: Phenomenal journey of the pharma industry

Hindustan Times  

The Indian pharmaceutical industry has come a long way since the country’s independence. Among private players, Khwaja Abdul Hamied had already set up one of India’s oldest pharma companies, Cipla in 1935; Indravan Modi set up Cadila pharmaceuticals in the early 1950s, Kallam Anji Reddy set up Dr Reddy’s Laboratories in Hyderabad and Bhai Parvinder Singh set up Ranbaxy in …

Are drugs manufactured in India safe? | In Focus podcast
2 years, 5 months ago

Are drugs manufactured in India safe? | In Focus podcast

The Hindu  

Earlier this month, the World Health Organisation issued a global warning about four cough syrups that it said were substandard products and were unsafe, and their use, especially in children, could “result in serious injury or death.” These four cough syrups Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup, were manufactured by …

Focus on innovation, government-industry synergy key for India to become pharmacy of the world
2 years, 6 months ago

Focus on innovation, government-industry synergy key for India to become pharmacy of the world

Firstpost  

The Indian pharma industry is strongly positioned in terms of production capacity and is also committed to growth Indian pharma industry currently ranks third in terms of pharmaceutical production by volume. A multi-pronged approach to innovation The R&D and clinical trials in the Indian pharma industry are traditionally risk-averse as they face several obstacles that may stifle innovation, such as …

Coming Soon: Research-linked Incentive Scheme to Rejuvenate Global Image of Indian Pharma Market
2 years, 9 months ago

Coming Soon: Research-linked Incentive Scheme to Rejuvenate Global Image of Indian Pharma Market

News 18  

With an aim of improving India’s position in the global pharmaceuticals market on the innovation index, the Narendra Modi government is preparing to launch a “research-linked incentive scheme”, News18.com has learnt. Planning India’s shift away from a low-value, high-volume player to a high-value, high-volume player in the global pharma market, the government is in discussions over the proposed scheme with …

Panacea or Pain for Pharma? Drug Price Watchdog to Meet Today on Reducing Prices of Key Medicines
2 years, 10 months ago

Panacea or Pain for Pharma? Drug Price Watchdog to Meet Today on Reducing Prices of Key Medicines

News 18  

With an eye on reducing the prices of critical medicines in the coming months, the National Pharmaceutical Pricing Authority will hold a meeting with big pharma companies on Friday, News18 has learnt. While non-scheduled medicines do not fall under the price control mechanism of the government, the TMR is a mode of price regulation by way of capping trade margins …

India takes another step towards becoming pharmacy of the world as exports grow by 103% since 2013-14
2 years, 10 months ago

India takes another step towards becoming pharmacy of the world as exports grow by 103% since 2013-14

Firstpost  

India’s top five pharma export destinations are the US, UK, South Africa, Russia and Nigeria. India’s pharma exports in 2021-22 sustained a positive growth despite the global trade disruptions and drop in demand for COVID-related medicines, it added. “Indian pharma companies enabled by their price competitiveness and good quality, have made a global mark, with 60 per cent of the …

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter
2 years, 11 months ago

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter

Live Mint  

The Indian pharmaceuticals sector has been under pressure from the ongoing Russia-Ukraine war as a majority of pharma companies have a strong presence in both countries. The report estimates EBITDA in 4QFY22E to be sequentially lower for the majority of Indian generic pharma companies on account of lower gross margins due to an increase in raw material costs and sustained …

Leapfrogging into the future of Indian pharma
2 years, 11 months ago

Leapfrogging into the future of Indian pharma

Hindustan Times  

Over the last two decades, the Indian pharma industry has grown leaps and bounds driven by its strength in the global generics space to the extent of being conferred the stature of becoming the pharmacy of the world. With a strong network of 3,000 drug companies and approximately 10,500 manufacturing units spread across the length and breadth of the country, …

How Trade Pact With UAE Will Boost Presence of Made-in-India Medicines in the Middle East
3 years, 1 month ago

How Trade Pact With UAE Will Boost Presence of Made-in-India Medicines in the Middle East

News 18  

The pact between India and the United Arab Emirates to boost bilateral merchandise trade is likely to expand the presence of Made-in-India medicines in Middle Eastern countries, chief of the central government’s pharma export arm has told News18.com. The reason behind India’s limited entry into the UAE market was its high consumption of patented drugs – innovative and expensive products …

Budgetary support could propel our quest for pharma innovation
3 years, 2 months ago

Budgetary support could propel our quest for pharma innovation

Live Mint  

The Indian pharmaceutical industry has been playing a key role in improving global health through its affordable and high-quality generic medicines. India will need to make exponential investments in R&D, manufacturing and digital transformations to become a global pharmaceutical innovation hub as well as achieve its vision of self-reliance in pharmaceuticals and biopharma. The government needs to urgently explore mechanisms …

Discover Related